President Donald Trump secured a major victory Friday as AstraZeneca agreed to lower its prescription drug prices for Medicaid—a move that follows a similar deal made by Pfizer and marks a center point in the administration's push for more affordable medicine.
According to AP, the agreement, made public during a White House Oval Office event, commits AstraZeneca to "most–favored–nation" pricing for Medicaid.
